相关实验视频

Updated: Feb 20, 2026

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

迪科林作为纤维化中的动态调节剂:机制,治疗潜力和未来的挑战

Wenqian Zhang¹, Shaozhe Cai¹, Jiayi Ma¹

¹Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, China.

Clinical immunology (Orlando, Fla.)

|February 18, 2026

概括

迪科林是一种蛋白质甘油,通过与生长因子和免疫细胞相互作用,显示出对纤维化有潜在的作用. 然而,其复杂的,特定阶段的作用为开发有效的抗纤维菌疗法带来了挑战.

科学领域:

生物化学生化学
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

纤维化是导致死亡的主要原因,需要新的治疗方法.
目前纤维化治疗的治疗策略有限.
迪科林是一种蛋白质甘油,是一种有前途的抗纤维化剂.

研究的目的:

审查在纤维化中的不同阶段的作用.
为了探索底层的机制decorine的抗纤维效应.
讨论基于decorin的干预措施的治疗潜力和挑战.

主要方法:

关于和纤维化的临床前和临床研究的文献综述.
对德科林与细胞因子,免疫细胞和细胞外基质组件的相互作用进行分析.
检查了在各种纤维状症中达科林的作用.

主要成果:

迪科林连接剂转化生长因子-β1 (TGF-β1),抑制纤维化.
迪科林调节免疫反应和细胞外矩阵蛋白酶.
迪科林表现出特定阶段的作用,具有保护性,抗纤维性或炎症性作用.

结论:

迪科林的多方面的作用为纤维化提供了治疗前景.
了解德科林的依赖阶段的功能对于有效治疗至关重要.
需要进一步的研究,以克服利用Decorin抗纤维菌疗效的挑战.

关键词:

在 Decorin Decorin 中使用.纤维母细胞细胞是如何形成的纤维化纤维化纤维化巨细胞是一个巨细胞.

更多相关视频

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels

Author Spotlight: Understanding Chronic Lung Diseases Using 3D Printed Phototunable Hydrogels

Published on: June 30, 2023

Author Spotlight: Dissection and Isolation of Region-Specific Decellularized Lung Tissue

Author Spotlight: Dissection and Isolation of Region-Specific Decellularized Lung Tissue

Published on: September 29, 2023

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...